|
Market Cap (5-Jul) $758,238,016 (475th) |
Close (30-Jun) $0.056 |
Volume (30-Jun) 1,984,515 |
Shortsold (19-Jun) 895,750 (0.15%) (396th) |
|
52w High $2.09 |
52w Low $0.90 |
P/E - |
EPS -0.11 |
PYC released this announcement to the ASX on 22 February 2021, 9:44. The announcement is marked as price sensitive, and is 4 page(s) in length and 243.93kb in size.
You can view all announcements from PYC and see how they appear on a price chart on the announcements page.
At the date of this announcement, PYC was 0.000% short sold according to ASIC data. It was ranked the 610th most shorted stock on the ASX. It is now ranked as the 396th most shorted stock on the ASX with 0.154% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PYC | |
|---|---|
| FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL | 30 June 2023, 8:17 |
| Change of Director's Interest Notice | 28 June 2023, 16:46 |
| PYC Investor Update Presentation | 16 June 2023, 8:32 |
| Progress US Clinical Stage Company and Corporate Objectives | 22 February 2021, 9:44 |
| Change of Director's Interest Notice | 19 February 2021, 19:41 |
| PYC to Participate in RNA Discussion - CEO BIO Conference | 11 February 2021, 9:42 |
| Quarterly Activities Report and Appendix 4C | 29 January 2021, 17:47 |
You must be logged in to post a reply.
